Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FDX +5.3%
Other news:
- MPTI +4.7% (awarded production contract from US DoD prime contractor)
- KGEI +2.3% (announces TSX approval of normal course issuer bid)
- SKYE +2.3% (presents phase 1b data for its peripheral CB1-inhibiting antibody, nimacimab, at European Association for the Study of Diabetes Annual Meeting)
- NEOV +2.1% (celebrates RE+2025 successes & recaps announcements)
- PAC +1.9% (reports credit line refinancing for $40.0 mln)
- OLN +1.6% (to end joint venture with Mitsui & Co.)
- UPS +1.6% (in symptahy with FDX earnings; also terminates plan to acquire Estafeta)
- PPTA +1.6% (receives notice to proceed from US Forest Service authorizing project development)
- TTAN +1.5% (to acquire Conduit Tech)
- MNMD +1.4% (New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder)
- IONS +1.2% (announces that TRYNGOLZA has been approved in the European Union)
- BRR +1.1% (announces executive team and appreciation of its Bitcoin holdings)
- KALV +1% (receives EC and Swissmedic Approval of EKTERLY)